Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Serina Therapeutics (SER) Capital Leases (2019 - 2023)

Serina Therapeutics' Capital Leases history spans 2 years, with the latest figure at $1000.0 for Q4 2023.

  • For Q4 2023, Capital Leases changed N/A year-over-year to $1000.0; the TTM value through Dec 2023 reached $1000.0, changed N/A, while the annual FY2023 figure was $1000.0, N/A changed from the prior year.
  • Capital Leases for Q4 2023 was $1000.0 at Serina Therapeutics, down from $221000.0 in the prior quarter.
  • Across five years, Capital Leases topped out at $221000.0 in Q2 2019 and bottomed at $1000.0 in Q4 2023.